Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-08-27
1994-05-03
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514338, 514365, 514444, 514450, 514451, 514460, 546270, 546283, 546284, 546268, 548203, 549 60, 549355, 549414, 549420, 549423, A61K 31445, A61K 31335, C07D30910, C07D30902
Patent
active
053088522
ABSTRACT:
Compounds having the formula I: ##STR1## are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis and allograft rejection and in preventing the formation of atherosclerotic plaques.
REFERENCES:
patent: 4486445 (1984-12-01), Patel et al.
patent: 4937373 (1990-06-01), Carson et al.
The Merck Index, 11th ed., 5154, pp. 829 (1989).
Delorme Daniel
Dube Daniel
Ducharme Yves
Fortin Rejean
Girard Yves
Cintins Marianne M.
Daniel Mark R.
DiPrima Joseph F.
Hydorn Michael B.
Merck Frosst Canada Inc.
LandOfFree
Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2115260